109 filings
8-K
ZLAB
Zai Lab Limited
8 May 24
Zai Lab Announces First Quarter 2024
4:09pm
8-K
ZLAB
Zai Lab Limited
27 Feb 24
Zai Lab Announces Full-Year 2023
4:12pm
8-K
ZLAB
Zai Lab Limited
8 Feb 24
Entry into a Material Definitive Agreement
4:37pm
8-K
ZLAB
Zai Lab Limited
7 Nov 23
Zai Lab Announces Third Quarter 2023
4:10pm
8-K
ZLAB
Zai Lab Limited
7 Aug 23
Zai Lab Announces Second Quarter 2023
4:07pm
8-K
m5xdqpj1f5rxa8
6 Jul 23
Zai Lab Announces Promotion of Yajing Chen to Chief Financial Officer
4:14pm
8-K
q7exf
30 Jun 23
Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China
4:18pm
8-K
aqfdi1w mwv
20 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
2d94uhp
6 Jun 23
Other Events
8:08am
8-K
1qhiw
9 May 23
Zai Lab Announces First Quarter 2023
4:03pm
8-K
n7l236
31 Mar 23
Other Events
6:09am
8-K
enc4urfy2 4o97h26
1 Mar 23
Zai Lab Announces Full-Year 2022 Financial Results and Recent Corporate Updates
4:06pm
8-K
d68qd kci91misa
9 Jan 23
Zai Lab Appoints Michel Vounatsos
7:34am
8-K
gw80tho39x mn4qryx7p
5 Jan 23
Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
4:05pm
8-K
tdm 7hey7li8q2hx
9 Nov 22
Zai Lab Announces Third Quarter 2022
4:13pm
8-K
oaft0kpjazxfyuhv6
28 Oct 22
Departure of Directors or Certain Officers
4:56pm
8-K
2lbkuj7sbb9 h7v
27 Sep 22
Entry into a Material Definitive Agreement
8:08am
8-K
b4snua69ysj q4f9ibg9
9 Aug 22
Zai Lab Announces Second Quarter 2022
12:00am
8-K
ahdot6shv07v
3 Aug 22
Departure of Directors or Certain Officers
4:10pm
8-K
dvig7nqd v899
22 Jun 22
Departure of Directors or Certain Officers
4:02pm